sarah-philo357.bsky.social
@SarahPhilo357 on X née twitter.
Postdoc studying potable water reuse; all views my own. Posting mostly about sports and science.
BS at ND '16, MS at Duke '18, PhD at U Washington '23
37 posts
280 followers
417 following
Prolific Poster
Conversation Starter
comment in response to
post
every time I see a post complaining about him I look for you reminding people he doesn’t wash his hands, the most certain thing since gravity
comment in response to
post
The Democrats on the House Science Committee have set up a website to collect stories from fired federal employees, anonymously if desired. Please amplify. (This helps the lawyers establish standing for bringing legal cases against the administration!)
democrats-science.house.gov/sciencefirings
comment in response to
post
If I study anxiety via threat-biased attention, the word "biased" gets me flagged. You can't design a study of humans without using at least one of the terms on the banned list, which means that biomedical, brain, social science research is now on ice in the USA
comment in response to
post
The idea that you can erase & eliminate “equity” from global health work is utterly ludicrous—redressing health equities IS global health
2/2
comment in response to
post
I’ve been thinking a lot about grad students funded by the NIH whose tuition and salary comes from the gov’t, will they be able to stay in school? Who is g going to cover their costs when everyone’s funding is gone? Also dooming the next generation of scientists.
comment in response to
post
Coincidentally wearing my NASA t-shirt today, thinking about the pale blue dot and Sagan’s vision of how studying the cosmos should broaden our perspectives.
comment in response to
post
It feels nice to think that all health problems would go away if we just ate better & touched grass, but there is never a simple solution.
And now a person who claims to have a simple solution will be guiding those decisions, likely putting ID prevention and treatment even more on the back burner
comment in response to
post
This isn't even considering the whole host of neglected infectious diseases that would NEVER get the necessary R&D without lots of different monetary incentives.
comment in response to
post
Drug companies have little monetary incentive to develop drugs for infectious diseases because the ROI on a drug people take for two weeks is much less than the ROI on a drug people take for the rest of their lives.
www.sciencedirect.com/science/arti...
comment in response to
post
It is well established that we aren't dedicating enough resources and attention to treatment and prevention of infectious diseases (i.e. antimicrobial resistance).
If we continue on our current trends, antimicrobial resistant infections will top cancer by 2050.